Seronegative myasthenia gravis

Seminars in Neurology
Angela VincentJ Newsom-Davis

Abstract

Some myasthenia gravis (MG) patients do not have detectable acetylcholine receptor (AChR) antibodies and have been termed "seronegative" (SNMG) in many previous studies. A high proportion of patients with purely ocular symptoms, ocular MG, are seronegative; this may be because the sensitivity of the assay is insufficient to detect low levels of circulating AChR antibodies and because of intrinsic differences in the ocular muscles that make them more susceptible to circulating factors. Seronegative generalized myasthenia is proving to be heterogeneous both clinically and immunologically. Plasma from SNMG patients often contains a factor, probably an immunoglobulin M antibody, that alters AChR function in in vitro assays, but its target is not yet clear. A variable proportion of SNMG patients have antibodies to the muscle-specific tyrosine kinase (MuSK). These antibodies are directed against the extracellular domain of MuSK and inhibit agrin-induced AChR clustering in muscle myotubes. Although the role of these antibodies in causing myasthenic symptoms in vivo has not been elucidated, MuSK antibodies appear to define a group of patients who are often female with bulbar weakness, contrasting with MuSK antibody-negative SNMG patien...Continue Reading

Citations

Sep 21, 2010·Journal of Neurology·Zohar Argov
Feb 8, 2013·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Rumi SatoTadashi Miyatake
Jul 6, 2007·Nature Clinical Practice. Neurology·Jordi Díaz-ManeraIsabel Illa
Apr 9, 2013·Clinical Obstetrics and Gynecology·Michael Varner
Nov 3, 2006·The Journal of Clinical Investigation·Bianca M Conti-FineHenry J Kaminski
Mar 8, 2012·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Alison R AmentaJustin R Fallon
Jul 16, 2005·Internal Medicine·Teruyuki Kurihara
May 9, 2012·Case Reports in Obstetrics and Gynecology·Sebastian BerlitRegine Schaffelder
Mar 29, 2013·Autoimmunity Reviews·Paola CavalcanteRozen Le Panse
Dec 14, 2011·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Gloria von GeldernKyra Becker
Mar 12, 2008·Seminars in Immunopathology·F Grus, D Sun
May 17, 2011·European Journal of Internal Medicine·Michal Haran, Ami Schattner
Sep 22, 2009·The Annals of Thoracic Surgery·Chao ChengJingxuan Pan
Jul 27, 2007·Muscle & Nerve·Koon Ho ChanVanda A Lennon
Jun 24, 2008·Annals of the New York Academy of Sciences·Angela VincentNick Willcox
Sep 17, 2011·Muscle & Nerve·Paola CavalcanteRenato Mantegazza
Mar 21, 2006·Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia·Jee-Young LeeAngela Vincent
Oct 19, 2005·La Revue de médecine interne·F DurandP Cathébras
Nov 21, 2015·Neurología : publicación oficial de la Sociedad Española de Neurología·F J Vázquez-RoqueD Rivero-Valerón
Aug 2, 2005·European Journal of Obstetrics, Gynecology, and Reproductive Biology·Simone FerreroNicola Ragni
Sep 14, 2015·Drugs & Aging·Nuha M Alkhawajah, Joel Oger
Dec 13, 2006·Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology·Maria E FarrugiaAngela Vincent
Apr 28, 2009·Journal of the Neurological Sciences·Thashi ChangAngela Vincent
Nov 30, 2012·Autoimmune Diseases·Annapurni Jayam TrouthJanaki Kalyanam
Sep 23, 2016·Journal of the Neurological Sciences·Lauren Gotterer, Yuebing Li
Jan 8, 2015·BMJ Case Reports·Ana Raquel NevesIsabel Santos Silva
Dec 15, 2005·Journal of Abnormal Psychology·Kim WrightImogen Newsom-Davis
Feb 28, 2008·Journal of Glaucoma·Franz H GrusNorbert Pfeiffer
Aug 25, 2005·Expert Review of Vaccines·Sylvia Cohen-Kaminsky, Florence Jambou
Jan 27, 2006·Annals of Neurology·Claire VandiedonckHenri-Jean Garchon
Aug 10, 2007·Expert Reviews in Molecular Medicine·Juliane S MüllerHanns Lochmüller
Aug 17, 2016·Journal of Neuro-ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society·Elan L GutermanJonathan C Horton
Sep 16, 2004·Current Opinion in Neurology·Daniel HantaïBruno Eymard
Feb 28, 2007·Muscle & Nerve·Miharu SamurakiMasahito Yamada
Jan 7, 2020·Journal of the Neurological Sciences·John Morren, Yuebing Li

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.